FDA recommending continue trial to support “traditional approval on gfr” is basically telling dimx to forget accelerated approval on protien-uria , not gonna happen. So in this ANN why they keep banging on about running a 2nd interim analysis for a “potential” accelerated conditional approval when fda has told them it’s not going to happen is just tone deaf imo.
my nephrology mate has been right all along about this
- Forums
- ASX - By Stock
- DXB
- Ann: Quarterly Appendix 4C and Activities Report
Ann: Quarterly Appendix 4C and Activities Report, page-17
-
- There are more pages in this discussion • 32 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add DXB (ASX) to my watchlist
|
|||||
Last
45.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $250.5M |
Open | High | Low | Value | Volume |
46.5¢ | 47.5¢ | 45.5¢ | $934.4K | 2.015M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
14 | 548864 | 45.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
46.0¢ | 35747 | 5 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
9 | 453731 | 0.450 |
1 | 68489 | 0.445 |
2 | 20570 | 0.440 |
2 | 27023 | 0.435 |
4 | 50806 | 0.430 |
Price($) | Vol. | No. |
---|---|---|
0.460 | 17769 | 1 |
0.465 | 71700 | 2 |
0.470 | 55000 | 1 |
0.480 | 91130 | 3 |
0.485 | 85000 | 2 |
Last trade - 16.10pm 16/08/2024 (20 minute delay) ? |
Featured News
DXB (ASX) Chart |